Clinical Trial Results:
A Phase II, Randomized, Double-blind, Placebo-controlled, Multi-center, Parallel Group Study Evaluating the Efficacy, Safety and Tolerability of JTT-130 Administered Twice Daily for 24 Weeks in Treatment-naïve, Metformin Only or Metformin plus Sulfonylurea -treated Obese Type 2 Diabetic Patients
Summary
|
|
EudraCT number |
2009-011965-10 |
Trial protocol |
HU CZ |
Global completion date |
07 May 2010
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
29 Mar 2019
|
First version publication date |
29 Mar 2019
|
Other versions |
|
Summary report(s) |
AT130-G-08-006 PROMOTE Study Results Synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.